Loading…
Based on limited metadata, this warning letter was issued to Guangzhou Shiruoni Cosmetics Co., Ltd, a cosmetics manufacturer, on December 7, 2021. The FDA classified the products involved as drugs rather than cosmetics, indicating potential misclassification or unapproved drug claims. Without access to the full warning letter text or specific subject line, the exact nature of the violations cannot be determined, though they likely relate to product classification, labeling, manufacturing, or safety concerns. The letter represents FDA enforcement action against the company's operations or products under drug regulatory authority.